Millennium Management’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.47M | Sell |
56,536
-453,944
| -89% | -$19.8M | ﹤0.01% | 2548 |
|
|
2025
Q1 | $14M | Buy |
510,480
+394,562
| +340% | +$10.8M | 0.01% | 1299 |
|
|
2024
Q4 | $4.66M | Buy |
115,918
+77,912
| +205% | +$3.13M | ﹤0.01% | 2037 |
|
|
2024
Q3 | $1.8M | Buy |
38,006
+19,720
| +108% | +$933K | ﹤0.01% | 2608 |
|
|
2024
Q2 | $546K | Sell |
18,286
-34,766
| -66% | -$1.04M | ﹤0.01% | 3168 |
|
|
2024
Q1 | $2.13M | Sell |
53,052
-45,244
| -46% | -$1.82M | ﹤0.01% | 2542 |
|
|
2023
Q4 | $2.5M | Sell |
98,296
-73,615
| -43% | -$1.87M | ﹤0.01% | 2341 |
|
|
2023
Q3 | $2.39M | Buy |
171,911
+116,710
| +211% | +$1.62M | ﹤0.01% | 2365 |
|
|
2023
Q2 | $1.27M | Buy |
+55,201
| New | +$1.27M | ﹤0.01% | 2777 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 4755 |
|
|
2022
Q4 | – | Sell |
-69,085
| Closed | -$1.5M | – | 4992 |
|
|
2022
Q3 | $1.5M | Buy |
+69,085
| New | +$1.5M | ﹤0.01% | 3074 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 5337 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 5410 |
|
|
2021
Q2 | – | Sell |
-127,727
| Closed | -$4.96M | – | 5185 |
|
|
2021
Q1 | $4.96M | Buy |
+127,727
| New | +$4.96M | ﹤0.01% | 2068 |
|
|
2020
Q4 | – | Sell |
-16,008
| Closed | -$517 | – | 4248 |
|
|
2020
Q3 | $517 | Buy |
+16,008
| New | +$517 | ﹤0.01% | 2832 |
|